Mice vaccinated with recombinant adenoviral vectors containing FAP cDNA produced FAP-specific cytotoxic T lymphocytes capable of destroying FAP-expressing CAFs, suggesting FAP as a potential target for elimination of CAFs that may develop immunogenic tumor vaccines [102]. The gene discussed is FAP; the disease is neoplasm.